These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36682606)

  • 1. Diagnostic significance of secondary bacteremia in patients with COVID-19.
    Nakagawara K; Kamata H; Chubachi S; Namkoong H; Tanaka H; Lee H; Otake S; Fukushima T; Kusumoto T; Morita A; Azekawa S; Watase M; Asakura T; Masaki K; Ishii M; Endo A; Koike R; Ishikura H; Takata T; Matsushita Y; Harada N; Kokutou H; Yoshiyama T; Kataoka K; Mutoh Y; Miyawaki M; Ueda S; Ono H; Ono T; Shoko T; Muranaka H; Kawamura K; Mori N; Mochimaru T; Fukui M; Chihara Y; Nagasaki Y; Okamoto M; Amishima M; Odani T; Tani M; Nishi K; Shirai Y; Edahiro R; Ando A; Hashimoto N; Ogura S; Kitagawa Y; Kita T; Kagaya T; Kimura Y; Miyazawa N; Tsuchida T; Fujitani S; Murakami K; Sano H; Sato Y; Tanino Y; Otsuki R; Mashimo S; Kuramochi M; Hosoda Y; Hasegawa Y; Ueda T; Takaku Y; Ishiguro T; Fujiwara A; Kuwahara N; Kitamura H; Hagiwara E; Nakamori Y; Saito F; Kono Y; Abe S; Ishii T; Ohba T; Kusaka Y; Watanabe H; Masuda M; Watanabe H; Kimizuka Y; Kawana A; Kasamatsu Y; Hashimoto S; Okada Y; Takano T; Katayama K; Ai M; Kumanogoh A; Sato T; Tokunaga K; Imoto S; Kitagawa Y; Kimura A; Miyano S; Hasegawa N; Ogawa S; Kanai T; Fukunaga K;
    J Infect Chemother; 2023 Apr; 29(4):422-426. PubMed ID: 36682606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of respiratory bacterial infections on mortality in Japanese patients with COVID-19: a retrospective cohort study.
    Nakagawara K; Kamata H; Chubachi S; Namkoong H; Tanaka H; Lee H; Otake S; Fukushima T; Kusumoto T; Morita A; Azekawa S; Watase M; Asakura T; Masaki K; Ishii M; Endo A; Koike R; Ishikura H; Takata T; Matsushita Y; Harada N; Kokutou H; Yoshiyama T; Kataoka K; Mutoh Y; Miyawaki M; Ueda S; Ono H; Ono T; Shoko T; Muranaka H; Kawamura K; Mori N; Mochimaru T; Fukui M; Chihara Y; Nagasaki Y; Okamoto M; Amishima M; Odani T; Tani M; Nishi K; Shirai Y; Edahiro R; Ando A; Hashimoto N; Ogura S; Kitagawa Y; Kita T; Kagaya T; Kimura Y; Miyazawa N; Tsuchida T; Fujitani S; Murakami K; Sano H; Sato Y; Tanino Y; Otsuki R; Mashimo S; Kuramochi M; Hosoda Y; Hasegawa Y; Ueda T; Takaku Y; Ishiguro T; Fujiwara A; Kuwahara N; Kitamura H; Hagiwara E; Nakamori Y; Saito F; Kono Y; Abe S; Ishii T; Ohba T; Kusaka Y; Watanabe H; Masuda M; Watanabe H; Kimizuka Y; Kawana A; Kasamatsu Y; Hashimoto S; Okada Y; Takano T; Katayama K; Ai M; Kumanogoh A; Sato T; Tokunaga K; Imoto S; Kitagawa Y; Kimura A; Miyano S; Hasegawa N; Ogawa S; Kanai T; Fukunaga K;
    BMC Pulm Med; 2023 Apr; 23(1):146. PubMed ID: 37101265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial/fungal infection in hospitalized patients with COVID-19 in a tertiary hospital in the Community of Castilla y León, Spain.
    Nebreda-Mayoral T; Miguel-Gómez MA; March-Rosselló GA; Puente-Fuertes L; Cantón-Benito E; Martínez-García AM; Muñoz-Martín AB; Orduña-Domingo A
    Enferm Infecc Microbiol Clin (Engl Ed); 2022 Apr; 40(4):158-165. PubMed ID: 35216948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.
    Hughes S; Troise O; Donaldson H; Mughal N; Moore LSP
    Clin Microbiol Infect; 2020 Oct; 26(10):1395-1399. PubMed ID: 32603803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risks and features of secondary infections in severe and critical ill COVID-19 patients.
    Zhang H; Zhang Y; Wu J; Li Y; Zhou X; Li X; Chen H; Guo M; Chen S; Sun F; Mao R; Qiu C; Zhu Z; Ai J; Zhang W
    Emerg Microbes Infect; 2020 Dec; 9(1):1958-1964. PubMed ID: 32815458
    [No Abstract]   [Full Text] [Related]  

  • 6. National surveillance of bacterial and fungal coinfection and secondary infection in COVID-19 patients in England: lessons from the first wave.
    Gerver SM; Guy R; Wilson K; Thelwall S; Nsonwu O; Rooney G; Brown CS; Muller-Pebody B; Hope R; Hall V
    Clin Microbiol Infect; 2021 Nov; 27(11):1658-1665. PubMed ID: 34481722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased rates of secondary bacterial infections, including
    DeVoe C; Segal MR; Wang L; Stanley K; Madera S; Fan J; Schouest J; Graham-Ojo R; Nichols A; Prasad PA; Ghale R; Love C; Abe-Jones Y; Kangelaris KN; Patterson SL; Yokoe DS; Langelier CR
    Infect Control Hosp Epidemiol; 2022 Oct; 43(10):1416-1423. PubMed ID: 34486503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of COVID-19 patients with bacterial coinfection admitted to the hospital from the emergency department in a large regional healthcare system.
    Lardaro T; Wang AZ; Bucca A; Croft A; Glober N; Holt DB; Musey PI; Peterson KD; Trigonis RA; Schaffer JT; Hunter BR
    J Med Virol; 2021 May; 93(5):2883-2889. PubMed ID: 33448423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing.
    Rawson TM; Moore LSP; Zhu N; Ranganathan N; Skolimowska K; Gilchrist M; Satta G; Cooke G; Holmes A
    Clin Infect Dis; 2020 Dec; 71(9):2459-2468. PubMed ID: 32358954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiologically confirmed infections and antibiotic-resistance in a national surveillance study of hospitalised patients who died with COVID-19, Italy 2020-2021.
    Floridia M; Giuliano M; Monaco M; Palmieri L; Lo Noce C; Palamara AT; Pantosti A; Brusaferro S; Onder G;
    Antimicrob Resist Infect Control; 2022 May; 11(1):74. PubMed ID: 35598032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial and fungal co-infections among ICU COVID-19 hospitalized patients in a Palestinian hospital: a retrospective cross-sectional study.
    Naseef HA; Mohammad U; Al-Shami N; Sahoury Y; Abukhalil AD; Dreidi M; Alsahouri I; Farraj M
    F1000Res; 2022; 11():30. PubMed ID: 35811795
    [No Abstract]   [Full Text] [Related]  

  • 12. State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia.
    Chong WH; Saha BK; Ananthakrishnan Ramani ; Chopra A
    Infection; 2021 Aug; 49(4):591-605. PubMed ID: 33709380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study.
    Garcia-Vidal C; Sanjuan G; Moreno-García E; Puerta-Alcalde P; Garcia-Pouton N; Chumbita M; Fernandez-Pittol M; Pitart C; Inciarte A; Bodro M; Morata L; Ambrosioni J; Grafia I; Meira F; Macaya I; Cardozo C; Casals C; Tellez A; Castro P; Marco F; García F; Mensa J; Martínez JA; Soriano A;
    Clin Microbiol Infect; 2021 Jan; 27(1):83-88. PubMed ID: 32745596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary infections in mechanically ventilated patients with COVID-19: An overlooked matter?
    Suarez-de-la-Rica A; Serrano P; De-la-Oliva R; Sánchez-Díaz P; Molinero P; Falces-Romero I; Ferrando C; Rello J; Maseda E
    Rev Esp Quimioter; 2021 Aug; 34(4):330-336. PubMed ID: 33764004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary infection in COVID-19 critically ill patients: a retrospective single-center evaluation.
    De Bruyn A; Verellen S; Bruckers L; Geebelen L; Callebaut I; De Pauw I; Stessel B; Dubois J
    BMC Infect Dis; 2022 Mar; 22(1):207. PubMed ID: 35236299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence, Presentation and Outcome of Secondary Bloodstream Infections among COVID-19 Patients.
    Samantaray S; Karan P; Sharma A; Nag V; Dutt N; Garg MK; Bhatia PK; Misra S
    Infect Disord Drug Targets; 2022; 22(5):e180422203723. PubMed ID: 35440319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Salmonella Bacteremia Accompanying COVID-19: The First Salmonella Co-Infection in the World Unrelated to Pakistan].
    Ürkmez FY; Atalay T
    Mikrobiyol Bul; 2022 Apr; 56(2):357-364. PubMed ID: 35477237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors.
    Ripa M; Galli L; Poli A; Oltolini C; Spagnuolo V; Mastrangelo A; Muccini C; Monti G; De Luca G; Landoni G; Dagna L; Clementi M; Rovere Querini P; Ciceri F; Tresoldi M; Lazzarin A; Zangrillo A; Scarpellini P; Castagna A;
    Clin Microbiol Infect; 2021 Mar; 27(3):451-457. PubMed ID: 33223114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infectious Complications in Severe Acute Pancreatitis: Pathogens, Drug Resistance, and Status of Nosocomial Infection in a University-Affiliated Teaching Hospital.
    Tian H; Chen L; Wu X; Li F; Ma Y; Cai Y; Song S
    Dig Dis Sci; 2020 Jul; 65(7):2079-2088. PubMed ID: 31691173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Impact of Staphylococcus aureus bacteremia in COVID-19 patients].
    Espinosa Perez M; García Fenoll R; Mormeneo Bayo S; Martínez Álvarez RM; Frutos Millán V; Villuendas Usón MC; Palacián Ruiz MP; Arbonés Mainar JM; Martínez Jiménez MC; Ramos Paesa C
    Rev Esp Quimioter; 2022 Oct; 35(5):468-474. PubMed ID: 35866373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.